EMCDDA trendspotter briefing – Impact of COVID-19 on patterns of drug use and drugrelated harms in Europe 2020 (EMCDDA)
Global Drug Survey – Special Edition on COVID-19 (Global Drug Survey)
August 11, 2020
Alcohol marketing in the WHO European Region – Update report on the evidence and recommend policy actions 2020 (WHO)
August 11, 2020
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) instigated a mixed-method trendspotter study to investigate the current situation. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug consumption patterns and drug-related harms during the early stages of the pandemic.
